{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:18:09Z","timestamp":1781842689680,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.oftal.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T22:00:18Z","timestamp":1529964018000},"page":"423-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Retinoblastoma: la importancia de su diagn\u00f3stico precoz"],"prefix":"10.1016","volume":"93","author":[{"given":"M.","family":"Parrilla-Vallejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Perea-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Relimpio-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Montero-de-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rodr\u00edguez-de-la-R\u00faa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Terr\u00f3n-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"D\u00edaz-Granda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Coca-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ponte-Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Espejo-Arjona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2018.04.010_bib0150","unstructured":"Tumores oculares y perioculares en la infancia. Retinoblastoma. En: American Academy of Ophthalmology (The eye M.D. Asociation). Oftalmolog\u00eda pedi\u00e1trica y estrabismo. Cap. 26. Madrid:Ed. Elsevier; 2007. pp. 390-399."},{"key":"10.1016\/j.oftal.2018.04.010_bib0155","first-page":"103","article-title":"Epidemiology and Rb1 gene of retinoblastoma","volume":"4","author":"Yun","year":"2011","journal-title":"Int J Ophthalmol."},{"key":"10.1016\/j.oftal.2018.04.010_bib0160","series-title":"Retinoblastoma, Cap. 22","first-page":"501","author":"Ryan","year":"2009"},{"key":"10.1016\/j.oftal.2018.04.010_bib0165","series-title":"Oncolog\u00eda cl\u00ednica Oft\u00e1lmicaSecci\u00f3n 6. Cap. 65","first-page":"171","article-title":"Retinoblastoma y gen\u00e9tica del c\u00e1ncer","author":"Singh","year":"2009"},{"key":"10.1016\/j.oftal.2018.04.010_bib0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/pbc.21163","article-title":"A phase II trial of carboplatin for intraocular retinoblastoma","volume":"49","author":"Dunkel","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.oftal.2018.04.010_bib0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/0191-3913-20040501-06","article-title":"Outcome of eyes with unilateral sporadic retinoblastoma based on the initial external findings by the family and the pediatrician","volume":"41","author":"Shields","year":"2004","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.oftal.2018.04.010_bib0180","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ophtha.2007.03.074","article-title":"Secondary acute myelogenous leukemia in patients with retinoblastoma: Is chemotherapy a factor?","volume":"114","author":"Gombos","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.04.010_bib0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.26039","article-title":"Analysis of retinoblastoma age incidence data using a fully stochastic cancer model","volume":"130","author":"Little","year":"2012","journal-title":"Int J Cancer."},{"key":"10.1016\/j.oftal.2018.04.010_bib0190","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/pbc.21970","article-title":"Familial retinoblastoma in developing countries","volume":"53","author":"Chantada","year":"2009","journal-title":"Pediatr Blood Cancer."},{"key":"10.1016\/j.oftal.2018.04.010_bib0195","unstructured":"Abelairas J, Alonso J, Balaguer J, Fern\u00e1ndez-Teijeiro A, Hern\u00e1ndez I, Mu\u00f1oz A, et al. Gu\u00eda de manejo del retinoblastoma. Grupo de trabajo de retinoblastoma. IV Congreso Nacional de la Sociedad Espa\u00f1ola de Hematolog\u00eda y Oncolog\u00eda pedi\u00e1tricas, Valencia. Mayo 2011."},{"key":"10.1016\/j.oftal.2018.04.010_bib0200","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1093\/humrep\/dep335","article-title":"Incidence of retinoblastoma in Dutch children conceived by IVF: An expanded study","volume":"24","author":"Marees","year":"2009","journal-title":"Hum Reprod."},{"key":"10.1016\/j.oftal.2018.04.010_bib0205","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","article-title":"The International Classification of Retinoblastoma predicts chemoreduction success","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.04.010_bib0210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-9394(02)01348-X","article-title":"Chemoreduction plus focal therapy for retinoblastoma: Factors predictive of need for treatment with external beam radiotherapy or enucleation","volume":"133","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftal.2018.04.010_bib0215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mpo.1353","article-title":"Chemotherapy for retinoblastoma","volume":"38","author":"Shields","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.oftal.2018.04.010_bib0220","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/mpo.1358","article-title":"Overview: Chemotherapy for retinoblastoma: an expanding area of clinical research","volume":"38","author":"Schouten-Van Meeteren","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.oftal.2018.04.010_bib0225","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.ophtha.2007.03.015","article-title":"Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?","volume":"114","author":"Wilson","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.04.010_bib0230","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archopht.120.4.460","article-title":"Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma","volume":"120","author":"Shields","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oftal.2018.04.010_bib0235","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archopht.118.11.1549","article-title":"Subconjunctival carboplatin in retinoblastoma. Impact of tumor burden and dose schedule","volume":"118","author":"Hayden","year":"2000","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.oftal.2018.04.010_bib0240","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1200\/JCO.2003.09.103","article-title":"Treatment of intraocular retinoblastoma with vincristine and carboplatin","volume":"21","author":"Rodriguez-Galindo","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oftal.2018.04.010_bib0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pbc.22503","article-title":"Results of a prospective study for the treatment of unilateral retinoblastoma","volume":"55","author":"Chantada","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.oftal.2018.04.010_bib0250","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology."},{"key":"10.1016\/j.oftal.2018.04.010_bib0255","doi-asserted-by":"crossref","unstructured":"Manjandavida FP, Honavar SG, Reddy VA, Khanna Rohit. Management and outcome of retinoblastoma with vitreous seeds. Ophthalmology. 2014; 121: 517-524.","DOI":"10.1016\/j.ophtha.2013.09.011"},{"key":"10.1016\/j.oftal.2018.04.010_bib0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3341\/kjo.2010.24.4.219","article-title":"Eye-preserving therapy in retinoblastoma: Prolonged primary chemotherapy alone or combined with local therapy","volume":"24","author":"Shin","year":"2010","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.oftal.2018.04.010_bib0265","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: A preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.04.010_bib0270","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archopht.123.11.1525","article-title":"Long-term visual outcome following chemoreduction for retinoblastoma","volume":"123","author":"Demirci","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oftal.2018.04.010_bib0275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjo.2008.139626","article-title":"Retinoblastoma: Treatment and survival in Great Britain 1963 to 2002","volume":"93","author":"MacCarthy","year":"2009","journal-title":"Br J Ophthalmol."},{"key":"10.1016\/j.oftal.2018.04.010_bib0280","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejca.2009.05.011","article-title":"Cancer mortality in long-term survivors of retinoblastoma","volume":"45","author":"Marees","year":"2009","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.oftal.2018.04.010_bib0285","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/cncr.23564","article-title":"Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers","volume":"113","author":"Sheen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.oftal.2018.04.010_bib0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/ICU.0b013e328338676a","article-title":"Retinoblastoma management: Advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy","volume":"21","author":"Shields","year":"2010","journal-title":"Curr Opin Ophthalmol"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669118301497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669118301497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T18:28:23Z","timestamp":1720376903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669118301497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0365669118301497"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2018.04.010","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinoblastoma: la importancia de su diagn\u00f3stico precoz","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}